IRADIMED CORPORATION (IRMD)
NASDAQ: IRMD · Real-Time Price · USD
94.57
+0.65 (0.69%)
At close: Dec 5, 2025, 4:00 PM EST
94.60
+0.03 (0.03%)
After-hours: Dec 5, 2025, 6:47 PM EST
IRADIMED CORPORATION Stock Forecast
Stock Price Forecast
The 1 analyst with a 12-month price forecast for IRADIMED CORPORATION stock has a target of 72, which predicts a decrease of -23.87% from the current stock price of 94.57.
Analyst Consensus: Strong Buy
* Price targets were last updated on Feb 14, 2025.
Analyst Ratings
According to 1 stock analyst, the rating for IRADIMED CORPORATION is "Strong Buy". This means that the analyst believes this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jul '25 | Aug '25 | Sep '25 | Oct '25 | Nov '25 | Dec '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 1 | 1 | 1 | 1 | 1 | 1 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Roth MKM | Roth MKM | Strong Buy Reiterates $60 → $72 | Strong Buy | Reiterates | $60 → $72 | -23.87% | Feb 14, 2025 |
| Roth MKM | Roth MKM | Strong Buy Maintains $65 → $60 | Strong Buy | Maintains | $65 → $60 | -36.55% | Aug 2, 2024 |
| Roth MKM | Roth MKM | Strong Buy Initiates $65 | Strong Buy | Initiates | $65 | -31.27% | Apr 22, 2024 |
| Roth Capital | Roth Capital | Strong Buy Maintains $32 → $36 | Strong Buy | Maintains | $32 → $36 | -61.93% | Aug 2, 2021 |
| Roth Capital | Roth Capital | Strong Buy Initiates $16 | Strong Buy | Initiates | $16 | -83.08% | Oct 31, 2017 |
Financial Forecast
Revenue This Year
84.35M
from 73.24M
Increased by 15.17%
Revenue Next Year
92.91M
from 84.35M
Increased by 10.15%
EPS This Year
1.90
from 1.50
Increased by 26.82%
EPS Next Year
2.16
from 1.90
Increased by 13.67%
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 87.0M | 95.8M | |
| Avg | 84.4M | 92.9M | |
| Low | 80.9M | 89.2M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 18.8% | 13.5% | |
| Avg | 15.2% | 10.1% | |
| Low | 10.4% | 5.7% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 1.96 | 2.23 | |
| Avg | 1.90 | 2.16 | |
| Low | 1.82 | 2.08 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 30.9% | 17.0% | |
| Avg | 26.8% | 13.7% | |
| Low | 21.5% | 9.2% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.